Amanta Healthcare Q4 Results Preview: Earnings Growth, Key Expectations & Outlook

Fri Mar 20 2026

Amanta Healthcare Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Amanta Healthcare was listed on the National Stock Exchange (NSE) on 09-Sep-2025. Amanta Healthcare share has its face value of 10 per share, and its NSE symbol is AMANTA. The company operates in the Healthcare sector and primarily belongs to the Pharmaceuticals industry.

Table of Contents

Amanta Healthcare Q4 Results 2026 Preview

Amanta Healthcare Q4 FY26 revenue is expected to be around Stable Performance, representing a 7-10% YoY increase compared to the same quarter last year.
Profit After Tax, or PAT, is projected to rise 8-12% YoY.
EBITDA to rise 7-10%.
Amanta Healthcare is expected to show Stable Performance in its revenue.

Click and Sign Up to Get Live Updates on Q4 Results

Amanta Healthcare Share Performance

Over the past six months, Amanta Healthcare share price has Up by 16% to 97.93.
Moreover, over the past year, the stock has Up by 28%
Despite this weak short-term performance, Amanta Healthcare stock has delivered a financially sound 140% return over the past 5 years.
As of today, 20-03-2026, the Amanta Healthcare share price is trading at 97.93 per share.

Key Factors to Watch for Amanta Healthcare Q4 Results FY26

Revenue Growth & Segment Performance – Focus on topline growth in the Pharmaceuticals industry within the Healthcare sector.
Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.

About Amanta Healthcare

Amanta Healthcare is a pharmaceutical company specializing in sterile injectables, infusion therapy, and medical devices, supplying hospitals and healthcare institutions in India and over 70 countries, with a focus on quality manufacturing and global exports.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Final Thoughts

Amanta Healthcare is gear up to announce its Q4 FY26 results. Analysts expect 7-10% revenue growth, a 8-12% rise in PAT, and a 7-10% rise in EBITDA. Amanta Healthcare focuses on revenue growth from order execution, margin improvement, a strong order book, and management.

Stay informed with Univest blogs to get real-time updates on Amanta Healthcare Q4 results FY26.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.